Therapeutic approaches for cholestatic liver diseases: the role of nitric oxide pathway.

[1]  M. Trauner,et al.  Novel therapeutic targets for cholestatic and fatty liver disease , 2021, Gut.

[2]  Fei Huang.  Ursodeoxycholic acid as a potential alternative therapeutic approach for neurodegenerative disorders: Effects on cell apoptosis, oxidative stress and inflammation in the brain , 2021, Brain, behavior, & immunity - health.

[3]  Yunxia Li,et al.  Advances of natural activators for Nrf2 signaling pathway on cholestatic liver injury protection: A review. , 2021, European journal of pharmacology.

[4]  K. Loomes,et al.  Alagille Syndrome: A Focused Review on Clinical Features, Genetics, and Treatment , 2021, Seminars in Liver Disease.

[5]  F. Abaalkhail,et al.  Cholestatic liver disease: Practice guidelines from the Saudi Association for the Study of Liver diseases and Transplantation , 2021, Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association.

[6]  A. Nakajima,et al.  Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents , 2021, Drugs.

[7]  A. Rabiee,et al.  Primary sclerosing cholangitis. , 2021, Translational gastroenterology and hepatology.

[8]  A. Benedetti,et al.  The Management of Cholestatic Liver Diseases: Current Therapies and Emerging New Possibilities , 2021, Journal of clinical medicine.

[9]  Chang-Yin Yu,et al.  Progress in research on the roles of TGR5 receptor in liver diseases , 2021, Scandinavian journal of gastroenterology.

[10]  M. Cagna,et al.  Changes in Glutathione Content in Liver Diseases: An Update , 2021, Antioxidants.

[11]  M. Ling,et al.  Curcumin protects radiation-induced liver damage in rats through the NF-κB signaling pathway , 2021, BMC Complementary Medicine and Therapies.

[12]  E. Rodriguez,et al.  Review: Pathogenesis of cholestatic liver diseases , 2020, World journal of hepatology.

[13]  H. El-Shorbagy,et al.  Chitosan protects liver against ischemia-reperfusion injury via regulating Bcl-2/Bax, TNF-α and TGF-β expression. , 2020, International journal of biological macromolecules.

[14]  A. Sahebkar,et al.  PPARγ: A turning point for irritable bowel syndrome treatment. , 2020, Life sciences.

[15]  Naihua Hu,et al.  The effect of emodin on liver disease - comprehensive advances in molecular mechanisms. , 2020, European journal of pharmacology.

[16]  X. Luan,et al.  Oligosaccharide attenuates aging‐related liver dysfunction by activating Nrf2 antioxidant signaling , 2020, Food science & nutrition.

[17]  M. Trauner,et al.  Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults. , 2020, Journal of hepatology.

[18]  M. Farzaei,et al.  Targeting mammalian target of rapamycin: prospects for the treatment of inflammatory bowel diseases. , 2020, Current medicinal chemistry.

[19]  Shizhang Wei,et al.  Natural products for the prevention and treatment of cholestasis: A review , 2020, Phytotherapy research : PTR.

[20]  Nengjiang Zhao,et al.  Corilagin Alleviates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced C57BL/6 Mice by Ameliorating Oxidative Stress and Restoring Autophagic Flux , 2020, Frontiers in Pharmacology.

[21]  R. Moriggl,et al.  Crosstalk between inflammatory mediators and endoplasmic reticulum stress in liver diseases. , 2019, Cytokine.

[22]  S. Kaneko,et al.  Lycopene Alleviates Obesity-Induced Inflammation and Insulin Resistance by Regulating M1/M2 Status of Macrophages. , 2019, Molecular nutrition & food research.

[23]  M. Razori,et al.  Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis. , 2019, Biochemical pharmacology.

[24]  Lanjuan Li,et al.  Protective role of melatonin in early‐stage and end‐stage liver cirrhosis , 2019, Journal of cellular and molecular medicine.

[25]  G. Zibari,et al.  Cholestatic liver diseases: An era of emerging therapies , 2019, World journal of clinical cases.

[26]  H. Falfushynska,et al.  Hepatoprotective Effect of Melatonin in Toxic Liver Injury in Rats , 2019, Medicina.

[27]  Liting Guo,et al.  Baicalin ameliorates neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the PI3K/AKT/FoxO1 pathway , 2019, Journal of Neuroinflammation.

[28]  S. Pereira,et al.  Molecular Pathogenesis of Cholangiocarcinoma , 2019, BMC Cancer.

[29]  M. Doumas,et al.  The Role of Statins in the Management of Nonalcoholic Fatty Liver Disease. , 2019, Current pharmaceutical design.

[30]  Haihua Feng,et al.  Corilagin alleviates acetaminophen-induced hepatotoxicity via enhancing the AMPK/GSK3β-Nrf2 signaling pathway , 2019, Cell Communication and Signaling.

[31]  Richard J. Thompson,et al.  Progressive Familial Intrahepatic Cholestasis. , 2018, Clinics in liver disease.

[32]  K. Loomes,et al.  Alagille Syndrome. , 2018, Clinics in liver disease.

[33]  Fares E. M. Ali,et al.  Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. , 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[34]  N. Stojanović,et al.  Exogenous putrescine affects polyamine and arginine metabolism in rat liver following bile ductus ligation. , 2018, Canadian journal of physiology and pharmacology.

[35]  D. Nichols,et al.  Inflammation in cystic fibrosis: An update , 2018, Pediatric pulmonology.

[36]  M. Farzaei,et al.  Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective , 2018, Nutrients.

[37]  D. Ezhilarasan.  Oxidative stress is bane in chronic liver diseases: Clinical and experimental perspective. , 2018, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

[38]  M. Manns,et al.  Autoimmune hepatitis , 2018, Nature Reviews Disease Primers.

[39]  M. Marzioni,et al.  Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[40]  Haiyang Xie,et al.  Baicalin Ameliorates Experimental Liver Cholestasis in Mice by Modulation of Oxidative Stress, Inflammation, and NRF2 Transcription Factor , 2017, Oxidative medicine and cellular longevity.

[41]  M. Rafeeq,et al.  Cystic fibrosis: current therapeutic targets and future approaches , 2017, Journal of Translational Medicine.

[42]  A. Ramachandran,et al.  Role of Oxygen Free Radicals, Nitric Oxide and Mitochondria in Mediating Cardiac Alterations During Liver Cirrhosis Induced by Thioacetamide , 2017, Cardiovascular Toxicology.

[43]  R. Houwen,et al.  Current and future therapies for inherited cholestatic liver diseases , 2017, World journal of gastroenterology.

[44]  J. Hampe,et al.  The ascending pathophysiology of cholestatic liver disease , 2017, Hepatology.

[45]  G. Pazour,et al.  Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness , 2017, Scientific Reports.

[46]  T. Tsai,et al.  Down-regulation of common NFκB-iNOS pathway by chronic Thalidomide treatment improves Hepatopulmonary Syndrome and Muscle Wasting in rats with Biliary Cirrhosis , 2016, Scientific Reports.

[47]  Ning Wang,et al.  Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases , 2016, Oxidative medicine and cellular longevity.

[48]  N. Marroni,et al.  Antioxidant and anti-inflammatory action of melatonin in an experimental model of secondary biliary cirrhosis induced by bile duct ligation , 2016, World journal of gastroenterology.

[49]  M. Davenport,et al.  Biliary atresia: A comprehensive review. , 2016, Journal of autoimmunity.

[50]  Y. Hong,et al.  The effect of sildenafil on right ventricular remodeling in a rat model of monocrotaline-induced right ventricular failure , 2016, Korean journal of pediatrics.

[51]  P. Hellstrand,et al.  Inhibition of Polyamine Uptake Potentiates the Anti‐Proliferative Effect of Polyamine Synthesis Inhibition and Preserves the Contractile Phenotype of Vascular Smooth Muscle Cells , 2016, Journal of cellular physiology.

[52]  R. Chapman,et al.  New Therapeutic Strategies for Primary Sclerosing Cholangitis , 2016, Seminars in Liver Disease.

[53]  Xiao-jian Zhang,et al.  Investigations of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic against α-naphthylisothiocyanate-induced cholestatic liver injury in rats. , 2015, Journal of ethnopharmacology.

[54]  M. Tokaç,et al.  Hepatoprotective and antioxidant effects of lycopene in acute cholestasis. , 2015, Turkish journal of medical sciences.

[55]  M. Kim,et al.  Nitric oxide in liver diseases. , 2015, Trends in pharmacological sciences.

[56]  J. Bezerra,et al.  Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes , 2015, Nature Reviews Gastroenterology &Hepatology.

[57]  M. Manns,et al.  Autoimmune hepatitis--Update 2015. , 2015, Journal of hepatology.

[58]  Liping Peng,et al.  Sodium Ferulate Reduces Portal Pressure Through Inhibition of RhoA/Rho-Kinase and Activation of Endothelial Nitric Oxide Synthase in Cirrhotic Rats , 2015, Digestive Diseases and Sciences.

[59]  Hong-yun Li,et al.  Thalidomide alleviates acute pancreatitis-associated lung injury via down-regulation of NFκB induced TNF-α. , 2014, Pathology, research and practice.

[60]  Min Wang,et al.  Sodium ferulate lowers portal pressure in rats with secondary biliary cirrhosis through the RhoA/Rho-kinase signaling pathway: A preliminary study , 2014, International journal of molecular medicine.

[61]  J. Kao,et al.  Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis , 2014, International journal of molecular sciences.

[62]  K. Głowniak,et al.  Phenolic acids in extracts obtained from the flowering herbs of Cirsium vulgare (Savi) Ten. growing in Poland , 2013 .

[63]  N. Başaran,et al.  Protective effects of curcumin against oxidative stress parameters and DNA damage in the livers and kidneys of rats with biliary obstruction. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[64]  H. Son,et al.  Protective effect of the roots extract of Platycodon grandiflorum on bile duct ligation-induced hepatic fibrosis in rats , 2013, Human & experimental toxicology.

[65]  W. Hua,et al.  Hepatoprotective evaluation of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic: In vitro and in vivo studies. , 2013, Journal of ethnopharmacology.

[66]  Prof. Mohammed Abdalla Hussein.  Prophylactic effect of resveratrol against ethinylestradiol-induced liver cholestasis. , 2013, Journal of medicinal food.

[67]  Y. Hwang,et al.  Protective effect of the aqueous extract from the root of Platycodon grandiflorum on cholestasis-induced hepatic injury in mice , 2012, Pharmaceutical biology.

[68]  G. Aydoğ,et al.  Sildenafil accelerates liver regeneration after partial hepatectomy in rats. , 2012, Transplantation proceedings.

[69]  Ai-Hua Zhang,et al.  Pretreatment with the total flavone glycosides of Flos Abelmoschus manihot and hyperoside prevents glomerular podocyte apoptosis in streptozotocin-induced diabetic nephropathy. , 2012, Journal of medicinal food.

[70]  R. Staud.  Effectiveness of CAM therapy: understanding the evidence. , 2011, Rheumatic diseases clinics of North America.

[71]  G. Hirschfield,et al.  Pathogenesis of cholestatic liver disease and therapeutic approaches. , 2010, Gastroenterology.

[72]  M. Ghasemi,et al.  Cholestasis induces apoptosis in mice cardiac cells: the possible role of nitric oxide and oxidative stress , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[73]  A. Kosters,et al.  The Role of Inflammation in Cholestasis: Clinical and Basic Aspects , 2010, Seminars in liver disease.

[74]  H. Kırımlıoğlu,et al.  Effect of leflunomide on liver regeneration after partial hepatectomy in rats , 2010, Pediatric Surgery International.

[75]  M. Kanter,et al.  Effects of sphingosylphosphorylcholine against cholestatic oxidative stress and liver damage in the common bile duct ligated rats. , 2009, Journal of pediatric surgery.

[76]  C. Marinangeli,et al.  Hypocholesterolemic and anti-obesity effects of saponins from Platycodon grandiflorum in hamsters fed atherogenic diets. , 2008, Journal of food science.

[77]  Yan Ding,et al.  Exploration of Emodin to treat alpha-naphthylisothiocyanate-induced cholestatic hepatitis via anti-inflammatory pathway. , 2008, European journal of pharmacology.

[78]  He-sheng Luo,et al.  Thalidomide prevents rat liver cirrhosis via inhibition of oxidative stress. , 2006, Pathology, research and practice.

[79]  H. Kırımlıoğlu,et al.  Hepatic damage in biliary-obstructed rats is ameliorated by leflunomide treatment , 2006, Pediatric Surgery International.

[80]  H. Kırımlıoğlu,et al.  Protective effect of resveratrol against oxidative stress in cholestasis. , 2005, The Journal of surgical research.

[81]  D. Pratt.  Cholestasis and cholestatic syndromes , 2005, Current opinion in gastroenterology.

[82]  C. Bucca,et al.  Source of exhaled nitric oxide in primary biliary cirrhosis. , 2004, Chest.

[83]  S. Y. Kim,et al.  Inhibition of prostaglandin E2 production by platycodin D isolated from the root of Platycodon grandiflorum. , 2001, Planta medica.

[84]  C. Castellani,et al.  Cystic fibrosis: a clinical view , 2016, Cellular and Molecular Life Sciences.

[85]  J. Drenth.  EASL Clinical Practice Guidelines: Autoimmune hepatitis. , 2015, Journal of hepatology.

[86]  H. Son,et al.  Platycodin D attenuates bile duct ligation-induced hepatic injury and fibrosis in mice. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[87]  F. Murad,et al.  Nitric oxide (NO): Biogeneration, regulation, and relevence to human diseases , 2003 .